Progressive multifocal leukoencephalopathy (PML) following autologous peripheral blood stem cell transplantation for multiple myeloma
- Resource Type
- Authors
- Peter R. E. Johnson; Peter M Fernandes; Karina Bennett; Neill P. F. Storrar
- Source
- Bennett, K M, Storrar, N, Johnson, P & Fernandes, P M 2020, ' Progressive multifocal leukoencephalopathy (PML) following autologous peripheral blood stem cell transplantation for multiple myeloma ', Clinical Case Reports, vol. 8, no. 6, pp. 938-943 . https://doi.org/10.1002/ccr3.2612
Clinical Case Reports, Vol 8, Iss 6, Pp 938-943 (2020)
Clinical Case Reports
- Subject
- Pathology
medicine.medical_specialty
Referral
lcsh:Medicine
Case Report
Case Reports
autologous peripheral blood stem cell transplantation
030204 cardiovascular system & hematology
Multidisciplinary team
progressive multifocal leukoencephalopathy
03 medical and health sciences
0302 clinical medicine
medicine
In patient
Multiple myeloma
lcsh:R5-920
business.industry
Progressive multifocal leukoencephalopathy
lcsh:R
General Medicine
medicine.disease
multiple myeloma
030220 oncology & carcinogenesis
Peripheral Blood Stem Cell Transplantation
business
lcsh:Medicine (General)
human activities
- Language
- English
PML should be considered in patients with neurological symptoms following MM and in those who are immunosuppressed. Symptoms are diverse and often rapidly progressing. Prompt referral and early involvement of the multidisciplinary team are crucial.